DeciBio

DeciBio is a specialized market research company providing reports in the biotech industry. We focus in the life science research and molecular diagnostics spaces, and some other niche fields as requested by our clients.

Our services include both off-the-shelf and tailored reports. We rely on primary and secondary research to provide actionable reports to our clients, which include top management consulting firms, as well as emerging and established life science companies.

Our reports provide the data and analysis to support due diligence and strategic planning efforts.

List of reports from DeciBio

Life Sciences Tools Market Size, Growth And Trends 4/12/2012 \| published by: DeciBio ... Top vendors include Agilent, Bio-Rad, EMD Millipore, Life Technologies (Invitrogen / Applied Biosystems), Roche, Sigma-Aldrich and Thermo Fisher; smaller emerging players are highlighted as well (e.g., genomics players [Fluidigm, Raindance, Oxford Nanopore, NABSys, GnuBio]). Segmenting ... \| more... Search inside this report	$2,200.00
Molecular Diagnostics: Market Size, Segmentation, Growth and Opportunities 2/15/2012 \| published by: DeciBio ... genotyping, MRSA screening) or the genetic markers of an individual patient (e.g., Her-2 overexpression for breast cancer, Factor V Leiden for coagulation). MDx tests continue to be the fastest growing segment within the IVD space, ... \| more... Search inside this report	$2,100.00
Next Generation Sequencing: Market Size, Segmentation, Growth and Trends by Provider 11/22/2011 \| published by: DeciBio ... the fastest growing and the most attractive segments of the $6.5B genomics space. With an estimated market size of ~$1.0B in 2011, and a double digit growth rate, NGS is poised to revolutionize not only ... \| more... Search inside this report	$1,600.00
Molecular Diagnostics: Market Segmentation and Opportunities 5/19/2011 \| published by: DeciBio ... (e.g., Her-2 overexpression in breast cancer). In recent years, MDx has experienced fast growth, given these tests high sensitivity, fast turnaround times and relatively low-cost compared to culture-based or immune-based techniques. MDx involves platforms and ... \| more... Search inside this report	$1,800.00
Durable Medical Equipment: U.S. Market Size, Segments, Growth and Trends 4/1/2011 \| published by: DeciBio ... or illnesses. Different stakeholders segment DME in different ways, making the market more or less inclusive. For the purpose of this report, we divided the DME market in six therapeutic segments: Home respiratory therapy Home ... \| more... Search inside this report	$1,800.00
Life Sciences Research Tools Market 2/19/2011 \| published by: DeciBio ... / Applied Biosystems), Sigma-Aldrich and Millipore. We divided this market in 5 broad segments: 1) pure genomics technologies (PCR, qPCR, digital PCR, CE sequencing, next generation sequencing (NGS) / third generation sequencing (3GS), microarrays, molecular ... \| more... Search inside this report	$2,100.00
Risk Evaluation and Mitigation Strategies (REMS) Trends and Implications for BioPharma 2/1/2011 \| published by: DeciBio ... (REMS) from drug sponsors. The primary objective of REMS is to enhance drug safety by ensuring that the benefits of a drug outweigh its risks. FDAAA 2007 became effective on March 25, 2008, when the ... \| more... Search inside this report	$1,400.00
Fluidigm Due Diligence: Company Profile, SWOT analysis and Market Opportunity 12/1/2010 \| published by: DeciBio ... the execution of thousands of experiments in parallel in nanoliter volumes, and facilitates implementation of experiments with a complex design. On December 3rd 2010, Fluidigm announced that it had refilled with the SEC to raise ... \| more... Search inside this report	$950.00
Qiagen Due Diligence: Company Profile, SWOT Analysis and Market Opportunity 10/18/2010 \| published by: DeciBio ... over the last few years, in part driven by increased exposure to MDx. Over the last few years, Qiagen has started a transition from life science research tools to molecular diagnostic (MDx), triggered by the ... \| more... Search inside this report	$850.00
Cepheid: Company SWOT Analysis 2/3/2010 \| published by: DeciBio ... diagnostics (MDx) market. Cepheid also offers NA tests in the agriculture, biothreat, environmental testing and food markets. In 2009, the ~$900M company reported total revenues of ~$171M and net loss of ~$22.5M. Cepheid’s revenue grew ... \| more... Search inside this report	$400.00